Add BrightSurf on Google Email

Cleveland researchers discover potential new treatment for Parkinson’s disease and other neurodegenerative conditions

Researchers have identified a promising drug to treat neurodegenerative conditions, including Alzheimer's disease and traumatic brain injury. The study found that inhibition of an enzyme called 15-PGDH was potently neuroprotective by restraining the production of reactive oxygen species that damage the brain.

A theoretical framework and hypothesis linking rubidium ion metabolic dysregulation to Parkinson’s disease pathogenesis

Researchers propose a theoretical framework linking rubidium ion metabolic dysregulation to Parkinson's disease, highlighting the role of ionic homeostasis imbalance in neurodegeneration. Rubidium may serve as a potential biomarker and therapeutic target for early intervention.

SourceChina Association of Chinese Medicine, eTM·JournalWorld Journal of Integrated Traditional and Western Medicine·TypeData/statistical analysis·DateJul 3, 2026

Study finds little to no cortical lewy pathology in living Parkinson’s disease patients undergoing deep brain stimulation

Researchers found that patients with Parkinson's disease showing little to no Lewy bodies despite long-standing, clinically advanced disease. The study provides new insight into the relationship between clinical symptoms and neuropathological progression.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·Journalnpj Parkinson s Disease·TypeObservational study·DateJul 1, 2026

Researchers affirm long-held belief that viruses can trigger Parkinson’s disease

A new study by Texas A&M University researchers uses a non-toxic virus to induce Parkinson's-like brain damage and movement problems in animal models. The breakthrough model confirms that viral infections can trigger Parkinson's disease, paving the way for future studies on early warning signs and biological markers.

SourceTexas A&M University·JournalBrain Behavior & Immunity - Health·TypeExperimental study·DateJun 29, 2026

Brain stimulation that adapts to Parkinson’s patients’ every step

Researchers created a personalized adaptive DBS system that detects neural signals associated with each step and adjusts stimulation in real time, improving gait symmetry and reducing falls. The study demonstrates the potential for brain stimulation to adapt to behavior itself, opening doors to future therapies.

SourceUniversity of California - San Francisco·JournalNature Medicine·TypeRandomized controlled/clinical trial·DateJun 15, 2026

Parkinson's disease, multiple sclerosis, ALS: behind the rising case numbers, distinct dynamics

A study analyzing French and Swedish national health databases reveals a rise in Parkinson's disease, multiple sclerosis, and motor neuron diseases' prevalence worldwide. Improved life expectancy and therapies contribute to the increase in multiple sclerosis cases, while population aging is the primary driver of ALS rising incidence.

SourceInstitut du Cerveau (Paris Brain Institute)·JournalNeurology·TypeData/statistical analysis·DateJun 8, 2026

Inexpensive material compresses light, paving the way for photonic microcircuits in the terahertz range

Researchers developed a new photonic material using lead iodide, enabling high-speed data transmission in the terahertz frequency range. The material confines light within submicrometer regions, paving the way for integrated photonic circuits that could replace or complement electronic circuits.

Aligning Science Across Parkinson’s and The Michael J. Fox Foundation Expand Global Research Initiative with $261M Investment Toward Personalized Treatments

A global research network, led by ASAP and MJFF, is expanding its efforts to map the biological blueprint of Parkinson's disease and develop a standardized toolkit of global research resources. This expansion aims to accelerate the development of personalized therapies by understanding the disease's inherent heterogeneity.

Re-conceptualizing Parkinson’s disease as a lifelong neurobiological trajectory: A framework for prevention

A new review proposes a prevention-focused framework for understanding Parkinson's disease risk, highlighting the role of early-life vulnerability, environmental exposures, and resilience factors. The study suggests that susceptibility to PD may begin earlier in life through interactions between biology and environment.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalNeuroprotection·TypeLiterature review·DateApr 28, 2026

Hydraulic brain: Body motion linked to fluid movement in the brain

A study using mice and simulations found that abdominal contractions compress blood vessels connected to the spinal cord and brain, enabling gentle brain movement that facilitates cerebrospinal fluid flow and potentially removes neural waste. This mechanism may explain why exercise is thought to benefit brain health.

SourcePenn State·JournalNature Neuroscience·DateApr 27, 2026

Use of psychotropics increases already in the early stages of Parkinson’s disease

A recent study from the University of Eastern Finland found that people with Parkinson's disease are using psychotropics more frequently than controls, even before diagnosis. The use of psychotropic medications increases as the disease progresses, reflecting emerging non-motor symptoms and worsening disease progression.

SourceUniversity of Eastern Finland·JournalBritish Journal of Clinical Pharmacology·DateApr 21, 2026

Scientists reverse brain aging, with a nasal spray

Researchers developed a nasal spray that reversibly reduces brain inflammation, restores cellular power plants, and improves memory. The treatment bypasses the brain's protective shield through intranasal delivery, suppressing chronic inflammation and promoting successful brain aging.

SourceTexas A&M University·JournalJournal of Extracellular Vesicles·DateApr 14, 2026

Chinese Medical Journal review illuminates the multifaceted role of LRRK2 in health and disease

The review highlights LRRK2's diverse cellular functions and pathogenic mechanisms in various diseases, including Parkinson's disease and inflammatory disorders. Therapeutic strategies targeting LRRK2, such as kinase inhibitors and emerging approaches like PROTACs and gene therapy, show promise for correcting cellular imbalances and re...

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeLiterature review·DateApr 1, 2026

What changes happen in the aging brain?

Researchers created the most comprehensive single-cell atlas of epigenetic changes in the aging mouse brain, revealing how DNA methylation, genome structure, and gene activity change across brain regions and cell types. The atlas has already shown clear epigenetic differences between different age groups and allowed the development of ...

SourceSalk Institute·JournalCell·DateMar 11, 2026

New study on early Parkinson’s disease progression highlights vital role of patient focused drug development and real-world impacts

A new study found that functional impairment worsened over time in individuals with early Parkinson's disease, despite plateaued symptoms, with gait, balance, and posture being the most bothersome issues. The study's results underscore the importance of incorporating real-world measures of disease progression in clinical trial design.

From the lab to the living room: Decoding Parkinson’s patients movements in the real world

Researchers from UC San Francisco successfully decoded brain activity patterns associated with walking, enabling the development of personalized neural biomarkers for movement state classification. This breakthrough could lead to more effective adaptive DBS systems that adjust stimulation in response to a patient's activity state.

SourceUniversity of California San Francisco Medical Center·JournalScience Advances·TypeExperimental study·DateFeb 13, 2026

A new roadmap spotlights aging as key to advancing research in Parkinson’s disease

A comprehensive roadmap identifies mouse models that incorporate aging as a central element of Parkinson's disease pathogenesis, fostering cooperation among researchers. The collaboration aims to make it easier for scientists to include aging in their efforts to tackle the incurable neurodegenerative motor disease.

SourceBuck Institute for Research on Aging·Journalnpj Parkinson s Disease·TypeSystematic review·DateFeb 11, 2026

Opening a new window on the brainstem, AI algorithm enables tracking of its vital white matter pathways

A new software tool developed by MIT researchers can reliably and finely resolve eight distinct nerve bundles in live diffusion MRI scans, shedding light on neurodegenerative diseases like Parkinson's and Alzheimer's. The BrainStem Bundle Tool (BSBT) reveals distinct patterns of structural changes in patients with these conditions.

SourcePicower Institute at MIT·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateFeb 9, 2026